Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy
Steven T. Szabo, Michael J. Thorpy, Geert Mayer, et al.
Sleep Medicine Reviews (2018) Vol. 43, pp. 23-36
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Recently Approved and Upcoming Treatments for Narcolepsy
Michael J. Thorpy
CNS Drugs (2020) Vol. 34, Iss. 1, pp. 9-27
Open Access | Times Cited: 96
Role of the locus coeruleus and basal forebrain in arousal and attention
Eden B. Maness, Joshua A. Burk, James T Mckenna, et al.
Brain Research Bulletin (2022) Vol. 188, pp. 47-58
Open Access | Times Cited: 40
Narcolepsy: Beyond the Classic Pentad
Anne Marie Morse, Sooyoung Kim, Shelby Freedman Harris, et al.
CNS Drugs (2025)
Open Access | Times Cited: 1
Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications
Michael J. Thorpy, Richard Bogan
Sleep Medicine (2019) Vol. 68, pp. 97-109
Closed Access | Times Cited: 64
Soporific effect of modified Suanzaoren Decoction on mice models of insomnia by regulating Orexin-A and HPA axis homeostasis
Yingjie Dong, Ning-Hua Jiang, Lianghui Zhan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112141-112141
Open Access | Times Cited: 55
The NAergic locus coeruleus-ventrolateral preoptic area neural circuit mediates rapid arousal from sleep
Liang Yue, Shi Wu, Anfeng Xiang, et al.
Current Biology (2021) Vol. 31, Iss. 17, pp. 3729-3742.e5
Open Access | Times Cited: 49
New drug approvals for 2019: Synthesis and clinical applications
Shuo Yuan, Bin Yu, Hong‐Min Liu
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112667-112667
Closed Access | Times Cited: 49
Polysomnographic nighttime features of narcolepsy: A systematic review and meta-analysis
Ye Zhang, Rong Ren, Linghui Yang, et al.
Sleep Medicine Reviews (2021) Vol. 58, pp. 101488-101488
Closed Access | Times Cited: 33
Genetic and neural mechanisms of sleep disorders in children with autism spectrum disorder: a review
Ji Qi, Sijia Li, Jun-Bo Zhao, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 12
Pitolisant and Other Histamine-3 Receptor Antagonists—An Update on Therapeutic Potentials and Clinical Prospects
Victoria Harwell, Pius S. Fasinu
Medicines (2020) Vol. 7, Iss. 9, pp. 55-55
Open Access | Times Cited: 24
The development of sleep/wake disruption and cataplexy as hypocretin/orexin neurons degenerate in male vs. female Orexin/tTA; TetO-DTA Mice
Yu Sun, Ryan K. Tisdale, Sunmee Park, et al.
SLEEP (2022) Vol. 45, Iss. 12
Open Access | Times Cited: 14
Genetics and epigenetics of rare hypersomnia
Maria P. Mogavero, Lourdes M. DelRosso, Oliviero Bruni, et al.
Trends in Genetics (2023) Vol. 39, Iss. 5, pp. 415-429
Closed Access | Times Cited: 8
Cerebrospinal fluid monoamine levels in central disorders of hypersomnolence
Lucie Barateau, Isabelle Jaussent, Julien Roeser, et al.
SLEEP (2021) Vol. 44, Iss. 7
Open Access | Times Cited: 19
A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy
Steven T. Szabo, Seth C. Hopkins, Robert Lew, et al.
Sleep Medicine (2023) Vol. 107, pp. 202-211
Open Access | Times Cited: 7
Pitolisant nanofibers: A promising frontier in drug delivery for narcolepsy - Formulation, optimisation, and characterization insights
J. Nandhini, Karthikeyan Elumalai, C. Jegatheshwaran, et al.
Biomedical Technology (2023) Vol. 6, pp. 9-16
Open Access | Times Cited: 7
Identification of mental health and quality of life outcomes in primary care databases in the UK: a systematic review
Helena Carreira, Rachael Williams, Helen Strongman, et al.
BMJ Open (2019) Vol. 9, Iss. 7, pp. e029227-e029227
Open Access | Times Cited: 22
Increased chin muscle tone during all sleep stages in children taking selective serotonin reuptake inhibitor antidepressants and in children with narcolepsy type 1
Raffaele Ferri, Maria P. Mogavero, Oliviero Bruni, et al.
SLEEP (2021) Vol. 44, Iss. 11
Open Access | Times Cited: 17
Anti-Tribbles Pseudokinase 2 (TRIB2)-Immunization Modulates Hypocretin/Orexin Neuronal Functions
Susumu Tanaka, Yoshiko Honda, Makoto Honda, et al.
SLEEP (2016)
Open Access | Times Cited: 19
Modulating the immune response with the wake-promoting drug modafinil: A potential therapeutic approach for inflammatory disorders
Adriano Zager
Brain Behavior and Immunity (2020) Vol. 88, pp. 878-886
Closed Access | Times Cited: 17
Pitolisant for treating patients with narcolepsy
Shuang Li, Junyi Yang
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 2, pp. 79-84
Closed Access | Times Cited: 16
Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder
Maria Pia Giannoccaro, Rocco Liguori, Giuseppe Plazzi, et al.
Nature and Science of Sleep (2021) Vol. Volume 13, pp. 557-577
Open Access | Times Cited: 14
Nicotinamide mononucleotide (NMN) and NMN-rich product supplementation alleviate p-chlorophenylalanine-induced sleep disorders
Chunyan Shen, Xiaoyi Li, Pan-Yu Ma, et al.
Journal of Functional Foods (2022) Vol. 91, pp. 105031-105031
Open Access | Times Cited: 10
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort
Carlotta Mutti, Valerio Brunetti, Michela Figorilli, et al.
Neurological Sciences (2022) Vol. 43, Iss. 9, pp. 5563-5574
Open Access | Times Cited: 10
Solriamfetol: First Global Approval
Anthony Markham
Drugs (2019) Vol. 79, Iss. 7, pp. 785-790
Closed Access | Times Cited: 16
Update on Research and Practices in Major Sleep Disorders: Part II—Insomnia, Willis‐Ekbom Disease (Restless Leg Syndrome), and Narcolepsy
Jindarat Chaiard, Terri E. Weaver
Journal of Nursing Scholarship (2019) Vol. 51, Iss. 6, pp. 624-633
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top